Print（PDF/253KB） Feb. 23, 2018 Corporate

Sumitomo Dainippon Pharma Appoints Hiroshi Nomura as President and CEO

Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Masayo Tada) announced today that at its meeting held on February 23, 2018, the Board of Directors decided the following new assignments of Representative Directors as described below.

1.New Assignments of Representative Directors

Name	New Position	Current Position
Masayo Tada	Representative Director, Chairman	Representative Director, President and CEO
Hiroshi Nomura	Representative Director, President and CEO	Representative Director, Executive Vice President

2.Reason for Changes

Sumitomo Dainippon Pharma has been working to realize its Mid-term Business Plan ending in fiscal 2017 and its Vision ("Aspire to be a globally active R&D-based company", "Contribute to medical care through leading-edge technologies"). As we have produced some positive achievements, in order to realize the Company's future sustainable growth, we decided to move to a new setup with Chairman and President to further strengthen its management functions.

3.Effective date

April 1, 2018

(Reference)

Brief Personal History of New President and CEO

Business Career
April 1981	Joined Sumitomo Chemical Co., Ltd.
December 2003	Sumitomo Pharmaceuticals Co., Ltd.
October 2005	Senior Director, Finance & Accounting, Sumitomo Dainippon Pharma Co., Ltd.
January 2008	Senior Director, Corporate Planning, the Company
June 2008	Executive Officer Senior Director, Corporate Planning; Finance & Accounting; Information System Panning, the Company
November 2009	Executive Officer Senior Director, International Business Strategic Planning and Management; Finance & Accounting; Information System Panning, the Company
June 2011	Executive Officer Deputy Executive Director, Sales and Marketing; External Affairs, the Company
February 2012	Executive Officer of the Company Vice Chair, Executive Vice President and CFO, Sunovion Pharmaceuticals Inc.
June 2012	Member, Board of Directors of the Company Vice Chair, Executive Vice President and CFO, Sunovion Pharmaceuticals Inc.
April 2014	Member, Board of Directors, Senior Executive Officer Global Corporate Management; Global Strategy & Business Development; External Affairs; Corporate Secretariat & Industry Affairs; Finance & Accounting; Regenerative & Cellular Medicine Office, the Company
December 2014	Member, Board of Directors, Senior Executive Officer Global Corporate Planning; Global Business Development; External Affairs; Corporate Secretariat & Industry Affairs; Finance & Accounting, Regenerative & Cellular Medicine Office, the Company
January 2016	Member, Board of Directors, Senior Executive Officer Global Corporate Planning; Global Business Development; External Affairs; Corporate Secretariat & Industry Affairs; Finance & Accounting, Regenerative & Cellular Medicine Office; Drug Development Division, the Company
April 2016	Member, Board of Directors, Executive Vice President External Affairs; Corporate Secretariat & Industry Affairs; Finance & Accounting; Drug Development Division; Special Assignments, the Company
April 2017	Representative Director, Executive Vice President Global Corporate Planning; External Affairs; Corporate Secretariat & Industry Affairs; Personnel; Finance & Accounting, the Company (up to the present)